Loading page…
Healthcare
Corcept Therapeutics Incorporat has an AlphaScore of 57/100 based on the 2026-10-11 data. Key metrics feature an exceptionally high gross margin of 98.3% and a net margin of 13.09%. A primary strength is its double-digit revenue growth of 12.79%. A significant risk is its very high price-to-earnings ratio of 269.31.
Written 11/10/2026, 00:38:18 UTC · Snapshot 11/10/2026